Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Turnidge

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Diagnostic Microbiology and Infectious Disease|August 2, 2002
In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-1999)Jan M Bell, John D Turnidge, Michael A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatographyJian Li, Robert W Milne, Roger L Nation, et al.
Communicable Diseases Intelligence Quarterly Report|February 14, 2008
Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial ResistanceJohn D Turnidge, Graeme R Nimmo, Julie Pearson, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2008
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18)Mariana Castanheira, Jan M Bell, John D Turnidge, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaJian Li, Roger L Nation, Robert W Milne, et al.
The Medical Journal of Australia|June 21, 2005
A community-based intervention to reduce antibiotic use for upper respiratory tract infections in regional South AustraliaWilliam B Dollman, Vanessa T LeBlanc, Lynette Stevens, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2015
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptideRonald N Jones, John D Turnidge, Greg Moeck, et al.
The Journal of Infection|April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)David J Farrell, John D Turnidge, Jan Bell, et al.
The Journal of Antimicrobial Chemotherapy|October 30, 2008
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance ProgramRodrigo E Mendes, Jan M Bell, John D Turnidge, et al.
The Medical Journal of Australia|November 18, 2016
Antimicrobial use in Australian hospitals: how much and how appropriate?John D Turnidge, Karin Thursky, Caroline S Chen, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Diagnostic Microbiology and Infectious Disease|August 2, 2002
In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-1999)Jan M Bell, John D Turnidge, Michael A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatographyJian Li, Robert W Milne, Roger L Nation, et al.
Communicable Diseases Intelligence Quarterly Report|February 14, 2008
Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-06: report from the Australian Group on Antimicrobial ResistanceJohn D Turnidge, Graeme R Nimmo, Julie Pearson, et al.
Antimicrobial Agents and Chemotherapy|December 31, 2008
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18)Mariana Castanheira, Jan M Bell, John D Turnidge, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaJian Li, Roger L Nation, Robert W Milne, et al.
The Medical Journal of Australia|June 21, 2005
A community-based intervention to reduce antibiotic use for upper respiratory tract infections in regional South AustraliaWilliam B Dollman, Vanessa T LeBlanc, Lynette Stevens, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2015
Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptideRonald N Jones, John D Turnidge, Greg Moeck, et al.
The Journal of Infection|April 6, 2010
The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)David J Farrell, John D Turnidge, Jan Bell, et al.
The Journal of Antimicrobial Chemotherapy|October 30, 2008
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance ProgramRodrigo E Mendes, Jan M Bell, John D Turnidge, et al.
The Medical Journal of Australia|November 18, 2016
Antimicrobial use in Australian hospitals: how much and how appropriate?John D Turnidge, Karin Thursky, Caroline S Chen, et al.
Pageof 11